Kelly A. Kramer - 26 Nov 2025 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
01 Dec 2025, 16:54:54 UTC
Prior SEC filing
30 Jul 2025
Next SEC filing
03 Dec 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Edward S. Son by by Power of Attorney for Kelly A. Kramer

Key filing fact

Kelly A. Kramer filed Form 4 for GILEAD SCIENCES, INC. (GILD) on 01 Dec 2025.

Key facts

  • This page summarizes Kelly A. Kramer's Form 4 filing for GILEAD SCIENCES, INC. (GILD).
  • 6 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 01 Dec 2025, 16:54.

Change

  • Previous filing in this sequence was filed on 30 Jul 2025.
  • Current net transaction value: -$258,695.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001629885 Primary reporting owner

Kramer Kelly A.

Relationship
Director
Address
333 LAKESIDE DRIVE, FOSTER CITY
Signature
/s/ Edward S. Son by by Power of Attorney for Kelly A. Kramer
Signature date
01 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GILD transaction

Common Stock

Options Exercise

Transaction value
$227,286
Shares
+2,806
Change %
+210%
Price
$81.00
Shares after
4,145
Date
26 Nov 2025
Ownership
Direct
Footnotes
F1
GILD transaction

Common Stock

Sale

Transaction value
$356,671
Shares
-2,806
Change %
-68%
Price
$127.11
Shares after
1,339
Date
26 Nov 2025
Ownership
Direct
Footnotes
F1
GILD transaction

Common Stock

Options Exercise

Transaction value
$227,205
Shares
+2,805
Change %
+209%
Price
$81.00
Shares after
4,144
Date
28 Nov 2025
Ownership
Direct
Footnotes
F1
GILD transaction

Common Stock

Sale

Transaction value
$356,516
Shares
-2,805
Change %
-68%
Price
$127.10
Shares after
1,339
Date
28 Nov 2025
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GILD transaction Derivative

Non-qualified Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-2,806
Change %
-50%
Price
$0.000000
Shares after
2,805
Date
26 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,806
Exercise price
$81.00
Footnotes
F1, F2
GILD transaction Derivative

Non-qualified Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-2,805
Change %
-100%
Price
$0.000000
Shares after
0
Date
28 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,805
Exercise price
$81.00
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 27, 2025.

Footnote F2

Options vest quarterly over the first year of service and were fully vested on August 19, 2017.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .